| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.9B | $17.2B | $16.5B | $15.2B | $13.0B | $2.9B | $2.8B | $2.8B |
| Cost of Revenue | $10.9B | $10.4B | $10.0B | $9.4B | $8.3B | $1.9B | $1.8B | $1.7B |
| Gross Profit | $7.0B | $6.8B | $6.5B | $5.8B | $4.7B | $1.0B | $1.1B | $1.1B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $4.5B | $4.1B | $3.9B | $3.6B | $3.2B | $0.8B | $0.9B | $0.8B |
| Operating Income | $2.5B | $2.6B | $2.6B | $2.2B | $1.5B | $0.3B | $0.2B | $0.3B |
| Net Income | $1.7B | $1.9B | $1.8B | $1.5B | $1.0B | $0.2B | $0.1B | $0.2B |
| EPS (Basic) | $35.47 | $38.84 | $36.39 | $30.22 | $19.94 | $3.14 | $1.89 | $3.71 |
| EPS (Diluted) | $35.40 | $38.71 | $36.23 | $30.06 | $19.84 | $3.12 | $1.88 | $3.68 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.0B | $8.8B | $8.1B | $7.6B | $6.6B | $6.3B | $6.0B | $5.9B |
| Current Assets | $5.5B | $5.7B | $5.3B | $5.0B | $4.0B | $3.9B | $3.6B | $3.6B |
| Cash & Equivalents | $0.6B | $1.0B | $0.7B | $0.3B | $0.2B | $0.6B | $0.4B | $0.5B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.9B | $2.3B | $1.8B | $2.0B | $1.5B | $1.4B | $1.7B | $1.5B |
| Stockholders' Equity | $3.7B | $3.4B | $3.1B | $2.4B | $1.9B | $1.8B | $1.9B | $1.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.0B | $2.1B | $2.0B | $1.3B | $0.9B | $1.1B | $1.0B | $1.1B |
| Investing Cash Flow | $-0.6B | $-0.5B | $-0.4B | $-0.3B | $-0.2B | $-0.2B | $-0.2B | $-0.2B |
| Capital Expenditures | $0.7B | $0.5B | $0.4B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $-1.8B | $-1.2B | $-1.3B | $-1.0B | $-1.0B | $-0.7B | $-1.0B | $-0.7B |